Back to Schonfeld Strategic Advisors LLC Schonfeld Strategic Advisors LLC

ASNDASND
Showing 7 of 28 quarters

Position history for Schonfeld Strategic Advisors LLCSchonfeld Strategic Advisors LLC's holdings in ASCENDIS PHARMA A/S

Schonfeld Strategic Advisors LLC previously held 0 shares of ASND (ASCENDIS PHARMA A/S), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$34.1M

Total Shares Change

-228,525

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$239.22
0
2025-Q4
Decreased
2,581
-93.3%
$550,3710.0%$209.34
0
2025-Q3
Increased
38,250
+1944.4%
$7.6M0.0%$191.60
44
2025-Q2
Decreased
1,871
-96.9%
$322,9330.0%$172.22
0
2025-Q1
Decreased
60,375
-56.4%
$9.4M0.1%$154.68
0
2024-Q4
Decreased
138,593
-39.4%
$19.1M0.1%$136.48
0
2024-Q3
Increased
228,525
+132.8%
$34.1M0.2%$144.62
56

Other major holders of ASND: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used